Publicaciones en colaboración con investigadores/as de Universidad de Extremadura (26)

2022

  1. Association between LAG3/CD4 Genes Variants and Risk for Multiple Sclerosis

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  2. Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor

    Molecular Neurobiology, Vol. 59, Núm. 6, pp. 3458-3466

2020

  1. Endothelial nitric oxide synthase (NOS3) rs2070744 polymorphism and risk for multiple sclerosis

    Journal of Neural Transmission, Vol. 127, Núm. 8, pp. 1167-1175

2017

  1. Delta-amino-levulinic acid dehydratase gene and essential tremor

    European Journal of Clinical Investigation, Vol. 47, Núm. 5, pp. 348-356

2016

  1. Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis

    Scientific Reports, Vol. 6

2015

  1. Heme Oxygenase 1 and 2 Common Genetic Variants and Risk for Essential Tremor

    Medicine, Vol. 94, Núm. 24, pp. e968

  2. The GSTP1 gene variant rs1695 is not associated with an increased risk of multiple sclerosis

    Cellular and Molecular Immunology, Vol. 12, Núm. 6, pp. 777-779

2014

  1. NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis

    BMC Neurology, Vol. 14, Núm. 1

2013

  1. LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis

    BMC Neurology, Vol. 13

  2. MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis

    Human Immunology, Vol. 74, Núm. 12, pp. 1705-1708

  3. No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population

    Pharmacogenetics and Genomics, Vol. 23, Núm. 11, pp. 587-590

  4. Vitamin D3 Receptor (VDR) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. H1-MAPT and the risk for familial essential tremor

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor

    Journal of Neurology, Vol. 258, Núm. 2, pp. 203-211

  2. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor

    Pharmacogenetics and Genomics, Vol. 21, Núm. 7, pp. 436-439

  3. LINGO1 gene analysis in Parkinson's disease phenotypes

    Movement Disorders, Vol. 26, Núm. 4, pp. 722-727

2010

  1. Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis

    European Journal of Neurology, Vol. 17, Núm. 2, pp. 335-338

  2. Impairment of rapid repetitive finger movements and visual reaction time in patients with essential tremor

    European Journal of Neurology, Vol. 17, Núm. 1, pp. 152-159

  3. Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor

    European Journal of Neurology, Vol. 17, Núm. 6, pp. 879-881

  4. Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis

    NeuroMolecular Medicine, Vol. 12, Núm. 3, pp. 217-223